69 related articles for article (PubMed ID: 7502376)
1. [Erythropoiesis in myelodysplastic syndrome detected by multiparameter flow cytometry].
Jensen IM; Jensen PD; Hokland ME; Hokland P; Ellegaard J
Ugeskr Laeger; 1995 Sep; 157(37):5092-6. PubMed ID: 7502376
[TBL] [Abstract][Full Text] [Related]
2. A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry.
Jensen IM; Hokland M; Hokland P
Leuk Res; 1993 Oct; 17(10):839-46. PubMed ID: 8412296
[TBL] [Abstract][Full Text] [Related]
3. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid.
Rogers CE; Bradley MS; Palsson BO; Koller MR
Exp Hematol; 1996 Apr; 24(5):597-604. PubMed ID: 8605964
[TBL] [Abstract][Full Text] [Related]
5. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.
Brada SJ; van de Loosdrecht AA; Koudstaal J; de Wolf JT; Vellenga E
Leuk Res; 2004 Sep; 28(9):921-5. PubMed ID: 15234568
[TBL] [Abstract][Full Text] [Related]
6. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
Wood PA; Hrushesky WJ; Klevecz R
Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
[TBL] [Abstract][Full Text] [Related]
7. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric assessment of peripheral blood contamination and proliferative activity of human bone marrow cell populations.
Abrahamsen JF; Lund-Johansen F; Laerum OD; Schem BC; Sletvold O; Smaaland R
Cytometry; 1995 Jan; 19(1):77-85. PubMed ID: 7705188
[TBL] [Abstract][Full Text] [Related]
9. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
Sarycheva TG; Tsvetaeva NV; Kozinets GI
Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
[TBL] [Abstract][Full Text] [Related]
10. [Study on apoptosis in myelodysplastic syndromes by DNA in situ end labelling combined with APAAP].
Li X; Pu Q; Liu Y; Shi J; Tao Y; Chang C; Jiang Q; Huang W
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):27-9. PubMed ID: 12015085
[TBL] [Abstract][Full Text] [Related]
11. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric DNA content in myelodysplastic syndromes.
Montecucco C; Riccardi A; Traversi E; Danova M; Ucci G; Mazzini G; Giordano P
Cytometry; 1983 Nov; 4(3):238-43. PubMed ID: 6661989
[TBL] [Abstract][Full Text] [Related]
13. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
14. The proliferative activity of myelopoiesis in myelodysplasia evaluated by multiparameter flow cytometry.
Jensen IM; Hokland P
Br J Haematol; 1994 Jul; 87(3):477-82. PubMed ID: 7993787
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
16. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
[TBL] [Abstract][Full Text] [Related]
18. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle modulation by hematopoietic growth factors in myelodysplastic syndromes: analysis by three-color flow cytometry.
Ogata K; An E; Kamikubo K; Tamura H; Yokose N; Dan K; Nomura T
Exp Hematol; 1997 Jan; 25(1):8-18. PubMed ID: 8989901
[TBL] [Abstract][Full Text] [Related]
20. Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation.
Wangen JR; Eidenschink Brodersen L; Stolk TT; Wells DA; Loken MR
Int J Lab Hematol; 2014 Apr; 36(2):184-96. PubMed ID: 24118926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
